Corrigendum | Open Access
Susanta Meher, Tushar Subhadarshan Mishra, Prakash Kumar Sasmal, Satyajit Rath, Rakesh Sharma, Bikram Rout, Manoj Kumar Sahu, "Corrigendum to “Role of Biomarkers in Diagnosis and Prognostic Evaluation of Acute Pancreatitis”", Journal of Biomarkers, vol. 2019, Article ID 9590414, 1 page, 2019. https://doi.org/10.1155/2019/9590414
Corrigendum to “Role of Biomarkers in Diagnosis and Prognostic Evaluation of Acute Pancreatitis”
Additionally, there is an error in the section “3.3. Trypsinogen” where the text reading “Both serum and urine concentrations rise within few hours of onset of disease and decline to normal level within 3 to 5 days” should be corrected to “Both serum and urine concentration of trypsinogen-2 remains elevated in AP for prolonged periods, possibly beyond 9 days in mild disease and a month in severe disease .”
- S. Meher, T. S. Mishra, P. K. Sasmal et al., “Role of biomarkers in diagnosis and prognostic evaluation of acute pancreatitis,” Journal of Biomarkers, vol. 2015, Article ID 519534, 13 pages, 2015.
- E. A. Kemppainen, J. I. Hedstrom, P. A. Puolakkainen et al., “Rapid measurement of urinary trypsinogen-2 as a screening test for acute pancreatitis,” The New England Journal of Medicine, vol. 336, no. 25, pp. 1788–1793, 1997.
- M. Mero, T. Schröder, R. Tenhunen, and M. Lempinen, “Serum phospholipase A2, immunoreactive trypsin, and trypsin inhibitors during human acute pancreatitis,” Scandinavian Journal of Gastroenterology, vol. 17, no. 3, pp. 413–416, 1982.
Copyright © 2019 Susanta Meher et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.